StratifiCare
StratifiCare is a game-changing medical diagnostics company that is committed to improving patient outcomes through cutting-edge predictive protein diagnostics and AI technology. Founded with the vision of empowering personalized medicine for tomorrow, StratifiCare has been on the mission to develop quality, innovative diagnostic tests to enable healthcare providers in delivering personalized curative therapies to every patient since 2015.
Its pipeline includes ground-breaking tests that can predict life-threatening complications from severe Dengue, and the effectiveness of internal radiation therapy on liver cancer patients. Its diverse team is passionate about making a positive social impact on patients, their families, and society as a whole, and pledges to contribute towards the United Nations Sustainable Development Goals and the World Bank/IFC Ethical Principles in Health Care (EPiHC).
For further enquiry, please contact Anthony Chua (Co-founder & CEO)